'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
DECIPHER LABS LIMITED
DECIPHER (BSE 524752) · ISIN INE643N01012 · Pharmaceuticals · Est. 1986 · listed 1995 · website
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹8.24 cr | ₹0.5 cr | ₹9 cr |
| 30 Sep 2025 standalone | ₹8.43 cr | ₹0.43 cr | ₹9.5 cr |
| 31 Mar 2025 standalone | ₹8.49 cr | ₹0.24 cr | ₹9.18 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 16.43% | 0.00% | — | 83.57% |
Latest filings
- Voting Results and Scrutinizer''s Report for 40th Annual General Meeting held on 30th September, 2026 at 11:00 AM. 30 September 2026 · BSE
- Outcome and Proceedings of 40th Annual General Meeting held on 30th September, 2026 at 11:00 AM. 30 September 2026 · BSE
- Intimation of Book Closure date and Cut Off Date for Annual General Meeting scheduled to be held on 30th September, 2026. 8 September 2026 · BSE
- Annual Report FY2025-26 (New) 8 September 2026 · BSE
- Notice of the 40th Annual General Meting for the Financial Year 2025-26 under regulation 34 of SEBI (LODR), Regulations 2015. 8 September 2026 · BSE
Other companies in Pharmaceuticals
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Ajanta Pharma Limited
- Alivus Life Sciences Limited
- Wockhardt Limited
- Morepen Laboratories Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 September 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.